<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50261">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01891929</url>
  </required_header>
  <id_info>
    <org_study_id>2012-A01676-37</org_study_id>
    <nct_id>NCT01891929</nct_id>
  </id_info>
  <brief_title>Cognitive Remediation and Sheltered Employment in Schizophrenia</brief_title>
  <acronym>RemedRehab</acronym>
  <official_title>Specific Cognitive Remediation for Schizophrenia (RECOS) and Sheltered Employment: a Multicentre Controlled Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sainte Anne Hospital (Paris)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clermont-de-l’Oise Hospital (Clermont-de-l’Oise)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint-Egrève Hospital (Saint-Egrève)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sainte-Gemmes-sur-Loire Hospital (Sainte-Gemmes-sur-Loire)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Niort Hospital (Niort)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sainte-Marguerite Hospital (Marseille)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Laborit Hospital (Poitiers)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM)</authority>
    <authority>France: Comittee for the Protection of Persons (CPP)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study, driven on schisophrenic patients, is aimed at :

        1. Measuring the efficiency of the cognitive remediation program RECOS (COgnitive
           REmediation in Schizophrenia) on the capacity of the patients suffering from
           schizophrenia to improve the integration in sheltered employment (ESAT and EA).

        2. Comparing the efficiency of the program of cognitive remediation RECOS (RECOS arm) to
           the one of an usual program of coverage/care (TAU arm = Treatment As Usual) on
           integration in sheltered employment of patients suffering from schizophrenia.

        3. Realizing a comparative analysis, in both arms, of :

             1. the number of working hours achieved in protected environment during the 6 months
                following the two programs (reported to the working time planned by the contract
                of employment)

             2. the duration of such employments in protected areas.

        4. Estimating the impact of RECOS on the neuropsychological variables, the symptomatology,
           the consciousness of the disorders(insight), the quality of life and the social
           autonomy before the treatment (month M0), at the end of the treatment (month M3), and 6
           months later (month M9), and looking for a correlation between the improvement of these
           parameters and sheltered employment.

        5. Estimating the impact of cognitive remediation on integration in sheltered employment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of worked hours during the first 6 months of the contract of employment</measure>
    <time_frame>Outcome measures are daily assessed during 6 months (M4 to M9)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compared evolution in both arms (RECOS and TAU) of the number of worked hours, with regard to the number of hours planned in the contract of employment, during the 6 months following the entry in protected working environment (i.e. an external, validated and strong measure of the capacity of the patient to fit professionally).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compared evolution of the neuropsychological and clinical balance sheets between the beginning and the end of the Cognitive Remediation period (or the end of the &quot;Treatment As Usual&quot; period for the TAU arm)</measure>
    <time_frame>Scores are assessed twice : at Month 0 (Inclusion), and at Month 3 (after Cognitive Remediation or Treatment As Usual).</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) at the moment of the inclusion (month M0), and after the period of Cognitive Remediation or Treatment as Usual (month M3).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compared evolution of the neuropsychological and clinical balance sheets during the 6 first months of working contract (i.e. following the end of the training Cognitive Remediation period or after the &quot;Treatment As Usual&quot; period for the TAU arm).</measure>
    <time_frame>Neuropsychological and clinical cores are assessed twice : at Month 3 (after Cognitive Remediation or Treatment As Usual), and at Month 9 (after 6 months of working period). Occupational integration (EATR) is assessed twice during the same period : after</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compared evolution, in both arms (RECOS and TAU) of the scores obtained in the different neuropsychological tests, and in the scales of occupational integration (EATR), clinical symptomatology (PANSS, questionnaires of insight, self-respect, well being, social autonomy, and cognitive complaint) after the training period of Remediation and at the moment of the entry in protected working environment (month M3), and 6 months later (month M9).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Chronic Schizophrenia</condition>
  <arm_group>
    <arm_group_label>RECOS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The RECOS program (COgnitive REmediation for Schizophrenia) was designed by SBT Company and adapted by Vianin et al (2007) for specific use in schizophrenia. It includes computer based and paper and pencil exercises that target 6 main cognitive functions (selective attention; verbal memory; visuo-spatiale attention and memory, working memory, reasoning, and speed of execution) which have been recommended by the MATRICS consensus. Each exercise has 10 difficulty levels. Allocation of the training modules in RECOS is determined according to the standard scores obtained in the comprehensive neuropsychological assessment. Each patient participates in the module corresponding to his/her most altered cognitive area.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAU (Treatment as Usual)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by every service of the various inquiring centers involved. No additional session will be proposed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>RECOS (COgnitive REmediation for Scizophrenia)</intervention_name>
    <description>Every RECOS patient will benefit, with his therapist, from 2 sessions of 1 hour of training per week over a 14 weeks period (M1 to M3), plus 1 hour per week of task to be realized at home. All in all, it is thus about a training period of 42 hours.
After remediation, the follow-up of the patient will be led by his therapist with monthly appointments during 6 months (M4 to M9).
In parallel, neuropsychological and clinical scores will be assessed before (M0) and after the training period (M3), as well as at the end of the study (M9). Working and relational abilities will be assessed at the beginning and at the end of the working period (M4 and M9).</description>
    <arm_group_label>RECOS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TAU (Treatment As Usual)</intervention_name>
    <description>The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by every service of the various inquiring centers involved. No additional session will be proposed.
In parallel, neuropsychological and clinical scores will be assessed before (M0) and after the training period (M3), as well as at the end of the study (M9). Working and relational abilities will be assessed at the beginning and at the end of the working period (M4 and M9).</description>
    <arm_group_label>TAU (Treatment as Usual)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 18 to 45 years.

          -  Schizophrenia according to the criteria of the DSM-IV-TR.

          -  Project of entry to ESAT or to EA in the 6 weeks which follow.

          -  IQ &gt; 70 (F-NART).

          -  Stable symptomatology during the month preceding the inclusion.

          -  Psychotropic treatment unchanged  during the month preceding the inclusion (change no
             more than 25 % posology).

          -  Overdrawn performances in at least one of the 6 functions estimated by the kit of
             neuropsychological tests.

          -  French mother tongue.

          -  Informed and signed consent by the patient.

          -  Agreement of the guardian (for protected adults).

          -  Membership in a national insurance scheme.

        Exclusion Criteria:

          -  Dependence and recent abuses of cannabis (&gt; 2 / week) or in any other substance
             (according to the criteria of the DSM-IV-TR), except tobacco.

          -  Neurological disorders of vascular, infectious or neurodegenerative origin;
             dyschromatopsie.

          -  Taking of medicine with somatic tropism having a cerebral or psychic impact (eg:
             corticoids).

          -  Simultaneous participation to any other program of remédiation targeting the
             neurocognitive deficits.

          -  Resistance to neuroleptic.

          -  Reading and writing not acquired.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas FRANCK, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Service of Rehabilitation (SUR) of the Vinatier Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Françoise AUGIER, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>University Service of Rehabilitation (SUR) of the Vinatier Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brice MARTIN, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>University Service of Rehabilitation (SUR) of the Vinatier Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Caroline DEMILY, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>University Service of the Novice or Atypical Psychoses of the Vinatier Hopsital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Michel DOREY, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>University Service of the Novice or Atypical Psychoses of the Vinatier Hopsital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle AMADO, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Center of Study and Clinical Research (CERC) of the  Ste Anne Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corinne LAUNAY, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Center of Study and Clinical Research (CERC) of the  Ste Anne Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Cécile BRALET, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Service CRISALID of the Clermont-de-l'Oise's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elisabeth GIRAUD-BARO, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Saint-Egrève's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julien DUBREUCQ, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Saint-Egrève's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Denis LEGUAY, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Centre de Santé Mentale Angevin (CESAME) of the Sainte-Gemmes-sur-Loire's Hopsital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pascal BLOCH, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Niort's Hopsital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christophe LANCON, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Sainte Marguerite Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric FAKRA, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Sainte Marguerite Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Michel ZAKOIAN, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Ecole Nationale de la statistique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian FRANCQ, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Ecole Nationale de la statistique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pascal VIANIN, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Centre hospitalier universitaire vaudois, Lausanne, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nathalie GUILLARD-BOUHET, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Henri Laborit Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aurélie Dubrulle</last_name>
    <phone>+(33) 4 78 78 37 96</phone>
    <email>aurelie.dubrulle@ch-le-vinatier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lydie Sartelet</last_name>
    <phone>+(33) 4 37 91 55 31 (pm)</phone>
    <email>lydie.sartelet@ch-le-vinatier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Le Vinatier Pôle Centre</name>
      <address>
        <city>Bron</city>
        <zip>69378</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicolas FRANCK, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Françoise AUGIER, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brice MARTIN, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Le Vinatier Pôle Est</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Caroline DEMILY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Michel DOREY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Clermont de l'Oise</name>
      <address>
        <city>Clermont de l'Oise</city>
        <zip>60607</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marie-Cécile BRALET, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ste Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eric FAKRA, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ste Marguerite</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christophe LANCON, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Niort</name>
      <address>
        <city>Niort</city>
        <zip>79000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pascal BLOCH, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Ste Anne</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Isabelle AMADO, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne LAUNAY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Henri Laborit</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nathalie GUILLARD-BOUHET, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de St-Egrève</name>
      <address>
        <city>Saint-Egrève</city>
        <zip>38120</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Elisabeth GIRAUD-BARO, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien DUBREUCQ, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Santé Mentale Angevin (CESAME)</name>
      <address>
        <city>Sainte-Gemmes-sur-Loire</city>
        <zip>49130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Denis LEGUAY, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Deppen P, Sarrasin Bruchez P, Dukes R, Pellanda V, Vianin P. [Cognitive remediation program for individuals living with schizophrenia (Recos): preliminary results]. Encephale. 2011 Sep;37(4):314-21. doi: 10.1016/j.encep.2011.02.002. Epub 2011 Apr 9. French.</citation>
    <PMID>21981893</PMID>
  </reference>
  <reference>
    <citation>Franck N, Duboc C, Sundby C, Amado I, Wykes T, Demily C, Launay C, Le Roy V, Bloch P, Willard D, Todd A, Petitjean F, Foullu S, Briant P, Grillon ML, Deppen P, Verdoux H, Bralet MC, Januel D, Riche B, Roy P; Members of Cognitive Remediation Network, Vianin P. Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial. Schizophr Res. 2013 Jun;147(1):68-74. doi: 10.1016/j.schres.2013.03.009. Epub 2013 Apr 9.</citation>
    <PMID>23583327</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 17, 2013</lastchanged_date>
  <firstreceived_date>June 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital le Vinatier</investigator_affiliation>
    <investigator_full_name>Nicolas FRANCK, Pr</investigator_full_name>
    <investigator_title>University professor - Hospital practitioner</investigator_title>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Cognitive Remediation</keyword>
  <keyword>Working abilities and social functioning</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
